Cognitive rehabilitation with patients having persistent, severe psychiatric disabilities.

Full Abstract

The effectiveness of cognitive rehabilitation in ameliorating the symptomatic, cognitive, and functional deficits associated with schizophrenia and schizoaffective disorders was assessed in this prospective study. Thirty-eight participants who met DSM-IV criteria were assigned to cognitive rehabilitation treatment or treatment as usual (TAU) groups, using the method of minimization to equalize groups on prognostic variables believed to affect outcome (i.e., duration and severity of illness, Clozapine). Participants were assessed at baseline, treatment end, and 3-month follow-up. Improvement across time was found for both groups in delayed visuospatial memory and visual information processing speed, and the participant's status on the prognostic variables was found to be related to level of performance on measures of delayed visuospatial memory, negative symptoms, and speech disturbance. However, the findings did not provide evidence that cognitive rehabilitation is associated with greater improvement than TAU. Nor did the findings indicate that prognosis interacted with treatment to produce differential treatment outcomes.

Learn Faster Today Improve your study skills

Author information

Author/s: Lewis, Lisa (L); Unkefer, Evelyn P (EP); O'Neal, Shaun Kelley (SK); Crith, Carol J (CJ); Fultz, Jim (J);

Affiliation: Hope Adult Residential Unit, Menninger Clinic, Topeka, KS 66606-0829, USA. lewisl(-atsign-)menninger.edu

Journal and publication information

Publication Type: Journal Article

Journal: Psychiatric rehabilitation journal (Psychiatr Rehabil J), published in United States. (Language: eng)

Reference: 2003-; vol 26 (issue 4) : pp 325-31

Dates: Created 2003/05/12; Completed 2003/09/15; Revised 2004/11/17;

PMID: 12739903, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Antipsychotic Agents - therapeutic use
Clozapine - therapeutic use
Cognition Disorders - diagnosis; etiology; therapy
Cognitive Therapy - methods
Diagnostic and Statistical Manual of Mental Disorders
Humans

Humans
Neuropsychological Tests
Prospective Studies
Psychotic Disorders - complications; diagnosis; drug therapy
Schizophrenia - complications; diagnosis; drug therapy
Severity of Illness Index

Associated Chemicals: Antipsychotic Agents (0) ; Clozapine (5786-21-0)

These are the highest related articles currently in the database:

See 100+ related articles.